ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-10E13326
Home | Market Reports | Health| Health Conditions
Global Idiopathic Thrombocytopenic Purpura ITP Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Research Report 2025

Code: QYRE-Auto-10E13326
Report
September 2025
Pages:61
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roch
Amgen Inc
Grifols Biologicals Inc.
GlaxoSmithKline PLC

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size

The global market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics was valued at US$ 462 million in the year 2024 and is projected to reach a revised size of US$ 578 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market

ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics.
The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Report

Report Metric Details
Report Name Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market
Accounted market size in year US$ 462 million
Forecasted market size in 2031 US$ 578 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Corticosteroids
  • Intravenous Immunoglobulin (IVIG)
  • Anti-D Immunoglobulin
  • Thrombopoietin Receptor Agonists (TPO-RA)
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roch, Amgen Inc, Grifols Biologicals Inc., GlaxoSmithKline Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market growing?

Ans: The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market size in 2031?

Ans: The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market size in 2031 will be US$ 578 million.

Who are the main players in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market report?

Ans: The main players in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market are Roch, Amgen Inc, Grifols Biologicals Inc., GlaxoSmithKline Plc

What are the Application segmentation covered in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market report?

Ans: The Applications covered in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market report?

Ans: The Types covered in the Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market report are Corticosteroids, Intravenous Immunoglobulin (IVIG), Anti-D Immunoglobulin, Thrombopoietin Receptor Agonists (TPO-RA), Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Corticosteroids
1.2.3 Intravenous Immunoglobulin (IVIG)
1.2.4 Anti-D Immunoglobulin
1.2.5 Thrombopoietin Receptor Agonists (TPO-RA)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Perspective (2020-2031)
2.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Growth Trends by Region
2.2.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Dynamics
2.3.1 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Industry Trends
2.3.2 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
2.3.3 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
2.3.4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Revenue
3.1.1 Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue
3.4 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio
3.4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2024
3.5 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Head office and Area Served
3.6 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Product and Application
3.7 Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Type
4.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Breakdown Data by Application
5.1 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2020-2031)
6.2 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025)
6.4 North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2020-2031)
7.2 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2020-2031)
9.2 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roch
11.1.1 Roch Company Details
11.1.2 Roch Business Overview
11.1.3 Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.1.4 Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
11.1.5 Roch Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.2.4 Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
11.2.5 Amgen Inc Recent Development
11.3 Grifols Biologicals Inc.
11.3.1 Grifols Biologicals Inc. Company Details
11.3.2 Grifols Biologicals Inc. Business Overview
11.3.3 Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.3.4 Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
11.3.5 Grifols Biologicals Inc. Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Introduction
11.4.4 GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
11.4.5 GlaxoSmithKline Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roch
Amgen Inc
Grifols Biologicals Inc.
GlaxoSmithKline PLC
List of Tables
 Table 1. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Corticosteroids
 Table 3. Key Players of Intravenous Immunoglobulin (IVIG)
 Table 4. Key Players of Anti-D Immunoglobulin
 Table 5. Key Players of Thrombopoietin Receptor Agonists (TPO-RA)
 Table 6. Key Players of Others
 Table 7. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2020-2025)
 Table 11. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2026-2031)
 Table 13. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Trends
 Table 14. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Drivers
 Table 15. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Challenges
 Table 16. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Restraints
 Table 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Players (2020-2025)
 Table 19. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2024)
 Table 20. Ranking of Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Headquarters and Area Served
 Table 23. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Product and Application
 Table 24. Global Key Players of Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2020-2025)
 Table 28. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Type (2026-2031)
 Table 30. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Application (2020-2025)
 Table 32. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue Market Share by Application (2026-2031)
 Table 34. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Roch Company Details
 Table 50. Roch Business Overview
 Table 51. Roch Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
 Table 52. Roch Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025) & (US$ Million)
 Table 53. Roch Recent Development
 Table 54. Amgen Inc Company Details
 Table 55. Amgen Inc Business Overview
 Table 56. Amgen Inc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
 Table 57. Amgen Inc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025) & (US$ Million)
 Table 58. Amgen Inc Recent Development
 Table 59. Grifols Biologicals Inc. Company Details
 Table 60. Grifols Biologicals Inc. Business Overview
 Table 61. Grifols Biologicals Inc. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
 Table 62. Grifols Biologicals Inc. Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025) & (US$ Million)
 Table 63. Grifols Biologicals Inc. Recent Development
 Table 64. GlaxoSmithKline Plc Company Details
 Table 65. GlaxoSmithKline Plc Business Overview
 Table 66. GlaxoSmithKline Plc Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Product
 Table 67. GlaxoSmithKline Plc Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025) & (US$ Million)
 Table 68. GlaxoSmithKline Plc Recent Development
 Table 69. Research Programs/Design for This Report
 Table 70. Key Data Information from Secondary Sources
 Table 71. Key Data Information from Primary Sources
 Table 72. Authors List of This Report


List of Figures
 Figure 1. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Picture
 Figure 2. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Corticosteroids Features
 Figure 5. Intravenous Immunoglobulin (IVIG) Features
 Figure 6. Anti-D Immunoglobulin Features
 Figure 7. Thrombopoietin Receptor Agonists (TPO-RA) Features
 Figure 8. Others Features
 Figure 9. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Others Case Studies
 Figure 14. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Report Years Considered
 Figure 15. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region: 2024 VS 2031
 Figure 18. Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Players in 2024
 Figure 19. Global Top Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Revenue in 2024
 Figure 21. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2020-2031)
 Figure 23. United States Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2020-2031)
 Figure 27. Germany Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Region (2020-2031)
 Figure 35. China Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2020-2031)
 Figure 43. Mexico Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Share by Country (2020-2031)
 Figure 47. Turkey Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Roch Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
 Figure 51. Amgen Inc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
 Figure 52. Grifols Biologicals Inc. Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
 Figure 53. GlaxoSmithKline Plc Revenue Growth Rate in Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microsecond and Nanosecond Pulsed Tumor Ablation Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1P20078
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Cardiology Accessories Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-27D16650
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Influenza A&B Rapid Test Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14U20151
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Global Intravascular Shockwave Therapy Device Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22F16675
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions